As investigation on disease-free survival demonstrated that in only reduced NDRG4 group, not preserved NDRG4 group, obese patients with colorectal cancer had higher risk of tumor relapse compared with those nonobese patients. This evidence concerns the gene NDRG4 and colorectal cancer.